BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26405155)

  • 1. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
    te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
    Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
    Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
    Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early presentation of osteonecrosis in acute lymphoblastic leukemia: Two children from the Nordic and Baltic cohort.
    Mogensen SS; Harila-Saari A; Frandsen TL; Lähteenmäki P; Castor A; Kohonen I; Schmiegelow K; Mäkitie O
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28521072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
    Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
    van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the Relationship Between
    Erdem M; Tüfekçi Ö; Kızıldağ S; Yılmaz Ş; Kızmazoğlu D; Eroğlu Filibeli B; Ören H
    Turk J Haematol; 2019 Feb; 36(1):12-18. PubMed ID: 30251958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. British OsteoNEcrosis Study (BONES) protocol: a prospective cohort study to examine the natural history of osteonecrosis in older children, teenagers and young adults with acute lymphoblastic leukaemia and lymphoblastic lymphoma.
    Amin N; Kinsey S; Feltbower R; Kraft J; Whitehead E; Velangi M; James B
    BMJ Open; 2019 May; 9(5):e027204. PubMed ID: 31122988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
    Kaushik A; Bansal D; Khandelwal N; Trehan A; Marwaha RK
    Indian Pediatr; 2009 Mar; 46(3):245-8. PubMed ID: 19213989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective bone ultrasound patterns during childhood acute lymphoblastic leukemia treatment.
    Mussa A; Bertorello N; Porta F; Galletto C; Nicolosi MG; Manicone R; Corrias A; Fagioli F
    Bone; 2010 Apr; 46(4):1016-20. PubMed ID: 20044045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group.
    Mattano LA; Sather HN; Trigg ME; Nachman JB
    J Clin Oncol; 2000 Sep; 18(18):3262-72. PubMed ID: 10986059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
    Halton JM; Atkinson SA; Fraher L; Webber C; Gill GJ; Dawson S; Barr RD
    J Bone Miner Res; 1996 Nov; 11(11):1774-83. PubMed ID: 8915786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
    J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skeletal-related side effects of acute lymphoblastic leukemia treatment in children].
    Beniczky NJ; Hosszú É; Erdélyi DJ; Müller J; Jakab Z; Kovács G
    Orv Hetil; 2020 Dec; 161(49):2086-2093. PubMed ID: 33279884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density in children with acute lymphoblastic leukemia.
    Inaba H; Cao X; Han AQ; Panetta JC; Ness KK; Metzger ML; Rubnitz JE; Ribeiro RC; Sandlund JT; Jeha S; Cheng C; Pui CH; Relling MV; Kaste SC
    Cancer; 2018 Mar; 124(5):1025-1035. PubMed ID: 29266176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
    Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
    Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
    Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
    Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
    Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.